DRY EYE DISEASE (DED)
Clinical trials for DRY EYE DISEASE (DED) explained in plain language.
Never miss a new study
Get alerted when new DRY EYE DISEASE (DED) trials appear
Sign up with your email to follow new studies for DRY EYE DISEASE (DED), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Blood-Derived eye drops offer new hope for dry eye sufferers
Disease control CompletedThis study tested whether eye drops made from a patient's own blood or from donated umbilical cord blood can improve dry eye symptoms. 80 adults with dry eye disease were randomly assigned to receive one of these blood-based drops. Researchers measured tear film stability, tear p…
Matched conditions: DRY EYE DISEASE (DED)
Phase: PHASE1, PHASE2 • Sponsor: G.Gennimatas General Hospital • Aim: Disease control
Last updated May 26, 2026 05:42 UTC
-
Light therapy shows promise for dry eye sufferers
Disease control CompletedThis study tested whether low-level light therapy combined with non-steroidal immunosuppressant eye drops (cyclosporine or tacrolimus) can improve dry eye symptoms. 160 adults with moderate to severe dry eye took part. The main goal was to see if the combination reduced symptoms …
Matched conditions: DRY EYE DISEASE (DED)
Phase: EARLY_PHASE1 • Sponsor: University of Seville • Aim: Disease control
Last updated May 26, 2026 04:37 UTC
-
New eye drops bring relief to dry eye sufferers
Symptom relief CompletedThis study tested a new preservative-free eye drop (Thealoz Total) in 30 adults with chronic dry eye disease and eye surface inflammation. Participants used the drops daily for 12 weeks. The goal was to see if the drops reduce eye redness and improve symptoms like dryness and dis…
Matched conditions: DRY EYE DISEASE (DED)
Sponsor: Laboratoires Thea • Aim: Symptom relief
Last updated May 26, 2026 06:00 UTC
-
New eye drops aim to soothe dry eyes without harsh side effects
Symptom relief CompletedThis study looked at whether 0.05% cyclosporine eye drops can help people with mild to moderate dry eye. 60 adults took part in a double-blind trial comparing the drops to standard artificial tears. The goal was to see if the drops reduce eye discomfort and improve tear film stab…
Matched conditions: DRY EYE DISEASE (DED)
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Symptom relief
Last updated May 26, 2026 05:58 UTC
-
Which eye drop feels better? study puts flarex and lotemax SM to the test
Symptom relief CompletedThis study tested how comfortable two different eye drops feel and how they affect vision. 40 adults with mild to moderate eye inflammation or dry eye received one drop of each medicine, one in each eye. Researchers asked participants to rate comfort and vision impact right after…
Matched conditions: DRY EYE DISEASE (DED)
Phase: PHASE4 • Sponsor: Harrow Inc • Aim: Symptom relief
Last updated May 26, 2026 05:58 UTC
-
Eye drop showdown: which works better for dry eyes during cataract surgery?
Symptom relief CompletedThis study tested two different eye drop treatments for people with dry eye disease who were having cataract surgery. One group used a single medication (rebamipide), while the other used a combination of two medications (diquafosol and cyclosporine). The goal was to see which ap…
Matched conditions: DRY EYE DISEASE (DED)
Phase: PHASE4 • Sponsor: Samsung Medical Center • Aim: Symptom relief
Last updated May 26, 2026 05:58 UTC
-
Which eye drop works faster for dry eyes? new study pits diquafosol against rebamipide
Symptom relief CompletedThis study tested two different eye drops—diquafosol and rebamipide—to see which one provides faster relief for dry eye disease. Thirty adults with dry eyes received one of the drops, and researchers measured tear production, eye comfort, and eye surface health 30 minutes later. …
Matched conditions: DRY EYE DISEASE (DED)
Phase: PHASE4 • Sponsor: Korea University Anam Hospital • Aim: Symptom relief
Last updated May 26, 2026 05:51 UTC
-
New eye drop shows promise for dry eye relief
Symptom relief CompletedThis study tested a new eye drop called TTAX03 in 74 people with mild to moderate dry eye disease. The main goal was to see if it is safe, and researchers also looked at how well it works compared to a saline (salt water) control. Participants received a single dose and were foll…
Matched conditions: DRY EYE DISEASE (DED)
Phase: PHASE2 • Sponsor: BioTissue Holdings, Inc • Aim: Symptom relief
Last updated May 26, 2026 05:42 UTC
-
Phone film fights dry eyes and strain in new study
Symptom relief CompletedThis study tested whether anti-reflective and circularly polarized films on smartphone screens can reduce dry eyes and eye strain caused by short, close-up phone use. 120 adults with mild nearsightedness used phones for 45 minutes in light or dark rooms. Researchers measured tear…
Matched conditions: DRY EYE DISEASE (DED)
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Symptom relief
Last updated May 22, 2026 14:01 UTC
-
Warm eye masks show promise for dry eye sufferers
Symptom relief CompletedThis study tested whether far infrared eye masks placed on acupoints around the eyes can improve dry eye symptoms. Thirty-one people with dry eye disease used the masks, and researchers measured changes in tear stability, gland health, and symptom scores after one month. The goal…
Matched conditions: DRY EYE DISEASE (DED)
Phase: NA • Sponsor: China Medical University Hospital • Aim: Symptom relief
Last updated May 19, 2026 11:47 UTC
-
Gut-Brain-Eye link? supplement shows promise for dry eye relief
Symptom relief CompletedThis study tested whether a dietary supplement could improve dry eye symptoms by changing the bacteria in the gut. Twenty adults with dry eye disease took the supplement for 8 weeks. Researchers measured tear production and eye surface health at the start and end of the study. Th…
Matched conditions: DRY EYE DISEASE (DED)
Phase: NA • Sponsor: Varol TUNALI • Aim: Symptom relief
Last updated May 11, 2026 20:39 UTC